Topic

Texas

A collection of 504 issues

How to Get Tysabri (Natalizumab) Covered by UnitedHealthcare in Texas: Complete Appeals Guide with Forms and Templates

Quick Answer: Getting Tysabri Covered by UnitedHealthcare in Texas UnitedHealthcare requires prior authorization for Tysabri (natalizumab) through OptumRx. You'll need TOUCH enrollment, JCV antibody results, recent MRI, and documentation of failed prior therapies. If denied, you have 180 days to appeal internally, then can request Texas external review

How to Get Takhzyro (Lanadelumab-flyo) Covered by UnitedHealthcare in Texas: Prior Authorization Guide & Appeal Process

Answer Box: Getting Takhzyro Covered by UnitedHealthcare in Texas UnitedHealthcare requires prior authorization for Takhzyro (lanadelumab-flyo) with step therapy requirements. Success rate for appeals is over 80% when properly documented. Your fastest path: 1) Have your specialist submit PA with complete HAE diagnosis, attack logs, and prior therapy failures to

If Galafold (Migalastat) Isn't Approved by Aetna (CVS Health) in Texas: Formulary Alternatives & Exception Paths

Quick Answer: If Aetna (CVS Health) denies Galafold (migalastat) in Texas, your main formulary alternatives are Fabrazyme (agalsidase beta) and Replagal (agalsidase alfa). For Galafold exceptions, you'll need genetic testing proving an amenable GLA variant, specialist documentation, and evidence of ERT contraindication or failure. File internal appeals within

Renewing Luxturna Approval with Cigna in Texas: Complete Guide to Annual Reauthorization

Answer Box: Luxturna Renewal with Cigna in Texas Cigna requires annual reauthorization for Luxturna if treatment extends beyond the initial approval period. Most patients receive this one-time gene therapy within their first authorization, but delayed administration or retreatment requests trigger renewal requirements. Fastest path to renewal: 1. Submit updated genetic

Myths vs. Facts: Getting Zolgensma (onasemnogene abeparvovec-xioi) Covered by Aetna (CVS Health) in Texas - Complete Appeals Guide

Answer Box: Getting Zolgensma Covered by Aetna in Texas Aetna (CVS Health) requires strict prior authorization for Zolgensma in Texas: patient under 24 months, confirmed bi-allelic SMN1 mutations, anti-AAV9 antibody titer ≤1:50, and certified gene therapy center administration. If denied, file internal appeal within 180 days, then request Independent

Work With Your Doctor to Get Signifor / Signifor LAR (pasireotide) Approved by Blue Cross Blue Shield in Texas: Provider Collaboration Guide

Answer Box: Getting Signifor LAR Approved by Blue Cross Blue Shield in Texas Signifor LAR (pasireotide) requires prior authorization from Blue Cross Blue Shield of Texas, with strict medical necessity criteria. Success depends on strong collaboration between you and your endocrinologist to document failed first-generation treatments and provide comprehensive biochemical

How to Get Nourianz (Istradefylline) Covered by Humana in Texas: Prior Authorization Guide, Appeals Process, and State Law Protections

Answer Box: Getting Nourianz (Istradefylline) Covered by Humana in Texas Quick Path to Approval: Most Humana plans require prior authorization for Nourianz (istradefylline), an adjunct therapy for Parkinson's "OFF" episodes. You'll need documentation of current carbidopa/levodopa treatment, evidence of 2.5+ hours of

How to Get Givlaari (givosiran) Covered by UnitedHealthcare in Texas: Complete Coding and Appeals Guide

Answer Box: To get Givlaari (givosiran) covered by UnitedHealthcare in Texas, you need prior authorization with specific documentation: confirmed acute hepatic porphyria diagnosis (ICD-10 E80.21), elevated ALA/PBG lab results, at least 2 documented attacks in 6 months, and evidence of hemin failure/intolerance. Submit via the UnitedHealthcare Provider

Do You Qualify for Breyanzi (lisocabtagene maraleucel) Coverage by Aetna (CVS Health) in Texas? Decision Tree & Next Steps

Answer Box: Your Path to Breyanzi Coverage in Texas Breyanzi (lisocabtagene maraleucel) requires prior authorization from Aetna CVS Health in Texas. You're likely eligible if you have relapsed/refractory large B-cell lymphoma after 2+ prior therapies, ECOG performance status 0-2, and treatment at a certified facility. First step

How to Get Rezlidhia (olutasidenib) Covered by Blue Cross Blue Shield of Texas: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Rezlidhia Covered by BCBS Texas Blue Cross Blue Shield of Texas covers Rezlidhia (olutasidenib) for relapsed/refractory AML with IDH1 mutation, but requires prior authorization with specific documentation. To get approval: 1) Gather IDH1 mutation test results and prior therapy records, 2) Submit PA request with medical